These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 16224194

  • 1. Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.
    Szyper-Kravitz M, Sheinberg P, Sidi Y, Schiffenbauer Y, Trubniykov E, Shoenfeld Y.
    Int Arch Allergy Immunol; 2005 Dec; 138(4):334-6. PubMed ID: 16224194
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C, Vollenhoven Rv.
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [Abstract] [Full Text] [Related]

  • 3. [The efficacy of mycophenolate mofetil for systemic lupus erythematosus].
    Suzuki D, Ogawa N, Sawada J, Kimoto O, Shimoyama K, Hayashi H.
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Aug; 32(4):263-8. PubMed ID: 19721347
    [Abstract] [Full Text] [Related]

  • 4. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K, Ross S, Benz K, Amann K, Dötsch J.
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus.
    Doherty T, Austin SK, Newell B, Kiely PD.
    Lupus; 2013 Feb; 22(2):213-5. PubMed ID: 23257406
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
    Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G.
    Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307
    [Abstract] [Full Text] [Related]

  • 7. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.
    Riskalla MM, Somers EC, Fatica RA, McCune WJ.
    J Rheumatol; 2003 Jul; 30(7):1508-12. PubMed ID: 12858449
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN, Karim Y, Cuadrado MJ.
    Lupus; 2005 Jul; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [Abstract] [Full Text] [Related]

  • 9. Successful desensitization to mycophenolate mofetil: a case report.
    Colakoğlu B, Unal D, Gelincik A, Büyüköztürk S.
    J Investig Allergol Clin Immunol; 2014 Jul; 24(6):439-40. PubMed ID: 25668896
    [No Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
    Mak A, Mok CC.
    Lupus; 2005 Jul; 14(10):856-8. PubMed ID: 16302683
    [Abstract] [Full Text] [Related]

  • 11. Desensitization to Mycofenolate Mofetil: a novel 12 step protocol.
    Smith M, Gonzalez-Estrada A, Fernandez J, Subramanian A.
    Eur Ann Allergy Clin Immunol; 2016 Jul; 48(4):147-8. PubMed ID: 27425171
    [Abstract] [Full Text] [Related]

  • 12. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
    Tsang HH, Trendell-Smith NJ, Wu AK, Mok MY.
    Lupus; 2010 Mar; 19(3):330-3. PubMed ID: 19897521
    [Abstract] [Full Text] [Related]

  • 13. A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.
    Hara R, Miyazawa H, Nishimura K, Momoi T, Nozawa T, Kikuchi M, Sakurai N, Kizawa T, Shimamura S, Yasuda S, Hiromura K, Sada KE, Kawaguchi Y, Tamura N, Takei S, Takasaki Y, Atsumi T, Mori M.
    Mod Rheumatol; 2015 Mar; 25(6):858-64. PubMed ID: 26215483
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.
    Mok CC.
    Scand J Rheumatol; 2007 Mar; 36(5):329-37. PubMed ID: 17963161
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
    Kazderova M, Jancova E, Rysava R, Merta M, Tesar V.
    Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.
    Mino Y, Naito T, Shimoyama K, Ogawa N, Kawakami J.
    Ann Clin Biochem; 2017 Jul; 54(4):490-494. PubMed ID: 27538768
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.
    Nannini C, Crowson CS, Matteson EL, Moder KG.
    Lupus; 2009 Apr; 18(5):394-9. PubMed ID: 19318390
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.
    Chang HK.
    J Korean Med Sci; 2005 Oct; 20(5):883-5. PubMed ID: 16224167
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Alba P, Karim MY, Hunt BJ.
    Lupus; 2003 Oct; 12(8):633-5. PubMed ID: 12945724
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
    Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR.
    J Rheumatol; 2005 Jun; 32(6):1047-52. PubMed ID: 15940766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.